Shigellosis Vaccine
Shigella flexneri 2a and S. sonnei bivalent invasin complex vaccine is developed
Published in Vaccine Weekly, May 17th, 2006
According to recent research from the United States, "Over 160 million cases of shigellosis occur annually worldwide, with the two most prevalent species being Shigella flexneri and S. sonnei. Protective immunity against Shigella infection is primarily directed at the lipopolysaccharide (LPS) of the homologous serotype, so it may be necessary to combine monovalent vaccines for multiple Shigella serotypes to construct a multivalent vaccine against predominant serotypes."
"Recently, we described a subcellular...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-05-17)
More Articles from Vaccine Weekly
- Anthrax Vaccine
Recombinant Bacillus anthracis protective antigen protects against inhalational challenge - Glioblastoma Multiforme
Study finds novel vaccine curbs brain tumor growth, increases survival - Hepatitis B Vaccine
Translocation motif of hepatitis B virus improves protein vaccination - Marburg Virus
Experimental vaccine protects nonhuman primates when given after exposure to Marburg virus - Anthrax
Studies from the United States and India advance knowledge in anthrax research - Apoptosis
Cancer apoptosis induced by novel microbial fermentation product - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
